Structure

Physi-Chem Properties

Molecular Weight:  482.14
Volume:  438.586
LogP:  0.674
LogD:  0.67
LogS:  -3.226
# Rotatable Bonds:  7
TPSA:  176.9
# H-Bond Aceptor:  12
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.228
Synthetic Accessibility Score:  4.874
Fsp3:  0.591
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.19
MDCK Permeability:  9.3199843831826e-05
Pgp-inhibitor:  0.009
Pgp-substrate:  0.77
Human Intestinal Absorption (HIA):  0.873
20% Bioavailability (F20%):  0.018
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.185
Plasma Protein Binding (PPB):  36.39505386352539%
Volume Distribution (VD):  0.622
Pgp-substrate:  26.583656311035156%

ADMET: Metabolism

CYP1A2-inhibitor:  0.02
CYP1A2-substrate:  0.063
CYP2C19-inhibitor:  0.023
CYP2C19-substrate:  0.421
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.075
CYP2D6-inhibitor:  0.006
CYP2D6-substrate:  0.235
CYP3A4-inhibitor:  0.105
CYP3A4-substrate:  0.06

ADMET: Excretion

Clearance (CL):  1.632
Half-life (T1/2):  0.778

ADMET: Toxicity

hERG Blockers:  0.129
Human Hepatotoxicity (H-HT):  0.224
Drug-inuced Liver Injury (DILI):  0.758
AMES Toxicity:  0.037
Rat Oral Acute Toxicity:  0.084
Maximum Recommended Daily Dose:  0.007
Skin Sensitization:  0.066
Carcinogencity:  0.421
Eye Corrosion:  0.003
Eye Irritation:  0.014
Respiratory Toxicity:  0.951

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC478232

Natural Product ID:  NPC478232
Common Name*:   4'-methoxycatalposide
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  RBPRKAIUQYKIOS-WDFVJLJTSA-N
Standard InCHI:  InChI=1S/C24H30O12/c1-31-12-4-2-11(3-5-12)22(30)35-20-13-6-7-32-23(16(13)24(10-26)21(20)36-24)33-9-15-18(28)19(29)17(27)14(8-25)34-15/h2-7,13-21,23,25-29H,8-10H2,1H3/t13-,14?,15+,16-,17?,18-,19?,20+,21+,23+,24-/m1/s1
SMILES:  [H][C@]12[C@H](OC[C@@H]3OC(CO)C(O)C(O)[C@@H]3O)OC=C[C@@]1([H])[C@H](OC(=O)C1=CC=C(OC)C=C1)[C@@H]1O[C@@]12CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota stem bark Medicinal Plant Garden, College of Pharmacy, Ewha Womans University 2013-DEC PMID[28787158]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. PMID[9599262]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC478232 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9595 High Similarity NPC194705
0.9542 High Similarity NPC206815
0.9392 High Similarity NPC478236
0.9392 High Similarity NPC478234
0.9359 High Similarity NPC301910
0.9359 High Similarity NPC130730
0.9315 High Similarity NPC478240
0.9286 High Similarity NPC474936
0.9272 High Similarity NPC229354
0.9267 High Similarity NPC475379
0.9267 High Similarity NPC158546
0.9267 High Similarity NPC289021
0.9257 High Similarity NPC473149
0.9167 High Similarity NPC476011
0.9161 High Similarity NPC138993
0.8994 High Similarity NPC282551
0.8986 High Similarity NPC116104
0.8986 High Similarity NPC88754
0.8986 High Similarity NPC237872
0.8986 High Similarity NPC263397
0.8986 High Similarity NPC302286
0.8968 High Similarity NPC475378
0.8954 High Similarity NPC478235
0.8947 High Similarity NPC117346
0.8947 High Similarity NPC240592
0.8926 High Similarity NPC473281
0.8926 High Similarity NPC77922
0.8882 High Similarity NPC96599
0.8851 High Similarity NPC46644
0.8808 High Similarity NPC37838
0.8774 High Similarity NPC89693
0.8774 High Similarity NPC478241
0.8774 High Similarity NPC229548
0.8773 High Similarity NPC470685
0.8765 High Similarity NPC21956
0.8734 High Similarity NPC179914
0.8733 High Similarity NPC475213
0.8733 High Similarity NPC152796
0.8725 High Similarity NPC80098
0.8716 High Similarity NPC49597
0.8701 High Similarity NPC147224
0.8693 High Similarity NPC308178
0.8675 High Similarity NPC251062
0.8675 High Similarity NPC184464
0.8675 High Similarity NPC296659
0.8675 High Similarity NPC202391
0.8634 High Similarity NPC109990
0.8609 High Similarity NPC186296
0.8606 High Similarity NPC195972
0.86 High Similarity NPC7518
0.86 High Similarity NPC159387
0.86 High Similarity NPC137501
0.86 High Similarity NPC154262
0.8571 High Similarity NPC145847
0.8544 High Similarity NPC475484
0.8526 High Similarity NPC474620
0.8526 High Similarity NPC269914
0.8526 High Similarity NPC478249
0.8516 High Similarity NPC161955
0.8506 High Similarity NPC18789
0.8491 Intermediate Similarity NPC478248
0.8487 Intermediate Similarity NPC242756
0.8477 Intermediate Similarity NPC79908
0.8467 Intermediate Similarity NPC220936
0.8467 Intermediate Similarity NPC31745
0.8447 Intermediate Similarity NPC478265
0.8442 Intermediate Similarity NPC143246
0.8442 Intermediate Similarity NPC119773
0.8442 Intermediate Similarity NPC474268
0.8442 Intermediate Similarity NPC475539
0.8442 Intermediate Similarity NPC291153
0.8438 Intermediate Similarity NPC187205
0.8431 Intermediate Similarity NPC471028
0.8378 Intermediate Similarity NPC114116
0.8377 Intermediate Similarity NPC475528
0.8366 Intermediate Similarity NPC478250
0.8354 Intermediate Similarity NPC134905
0.8354 Intermediate Similarity NPC180586
0.8354 Intermediate Similarity NPC36130
0.8354 Intermediate Similarity NPC203664
0.8344 Intermediate Similarity NPC182350
0.8333 Intermediate Similarity NPC189631
0.8333 Intermediate Similarity NPC294470
0.8323 Intermediate Similarity NPC286919
0.8323 Intermediate Similarity NPC474044
0.8323 Intermediate Similarity NPC475663
0.8323 Intermediate Similarity NPC474234
0.8323 Intermediate Similarity NPC329997
0.8323 Intermediate Similarity NPC226759
0.8312 Intermediate Similarity NPC63304
0.8302 Intermediate Similarity NPC137813
0.8293 Intermediate Similarity NPC120012
0.828 Intermediate Similarity NPC111785
0.8272 Intermediate Similarity NPC469384
0.8267 Intermediate Similarity NPC212729
0.8255 Intermediate Similarity NPC322503
0.8255 Intermediate Similarity NPC470143
0.825 Intermediate Similarity NPC194095
0.825 Intermediate Similarity NPC327032
0.825 Intermediate Similarity NPC191046
0.8247 Intermediate Similarity NPC293154
0.8243 Intermediate Similarity NPC475824
0.8235 Intermediate Similarity NPC51181
0.8228 Intermediate Similarity NPC227980
0.8228 Intermediate Similarity NPC104172
0.8228 Intermediate Similarity NPC88886
0.8221 Intermediate Similarity NPC208676
0.8221 Intermediate Similarity NPC130489
0.8219 Intermediate Similarity NPC175333
0.8212 Intermediate Similarity NPC471345
0.8208 Intermediate Similarity NPC299855
0.8208 Intermediate Similarity NPC96194
0.8205 Intermediate Similarity NPC473867
0.8199 Intermediate Similarity NPC10205
0.8187 Intermediate Similarity NPC257847
0.8187 Intermediate Similarity NPC157898
0.8182 Intermediate Similarity NPC31081
0.8182 Intermediate Similarity NPC65833
0.8182 Intermediate Similarity NPC245219
0.8161 Intermediate Similarity NPC189704
0.816 Intermediate Similarity NPC43761
0.8148 Intermediate Similarity NPC471405
0.8148 Intermediate Similarity NPC478266
0.8133 Intermediate Similarity NPC294722
0.8129 Intermediate Similarity NPC469367
0.8125 Intermediate Similarity NPC23253
0.8121 Intermediate Similarity NPC41009
0.8121 Intermediate Similarity NPC254819
0.8114 Intermediate Similarity NPC476067
0.8114 Intermediate Similarity NPC475121
0.8113 Intermediate Similarity NPC35097
0.8108 Intermediate Similarity NPC295970
0.8107 Intermediate Similarity NPC149502
0.8107 Intermediate Similarity NPC271755
0.8107 Intermediate Similarity NPC254071
0.8107 Intermediate Similarity NPC222665
0.8098 Intermediate Similarity NPC472860
0.8098 Intermediate Similarity NPC133984
0.8092 Intermediate Similarity NPC186746
0.8092 Intermediate Similarity NPC472132
0.8089 Intermediate Similarity NPC473147
0.8079 Intermediate Similarity NPC471029
0.8079 Intermediate Similarity NPC34456
0.8079 Intermediate Similarity NPC169398
0.8077 Intermediate Similarity NPC194938
0.8075 Intermediate Similarity NPC469699
0.8065 Intermediate Similarity NPC184053
0.8063 Intermediate Similarity NPC213723
0.8049 Intermediate Similarity NPC160780
0.8049 Intermediate Similarity NPC289811
0.8039 Intermediate Similarity NPC475195
0.8037 Intermediate Similarity NPC17521
0.8037 Intermediate Similarity NPC45165
0.8027 Intermediate Similarity NPC267733
0.8027 Intermediate Similarity NPC276047
0.8025 Intermediate Similarity NPC476364
0.8024 Intermediate Similarity NPC475979
0.8014 Intermediate Similarity NPC145287
0.8012 Intermediate Similarity NPC289438
0.8012 Intermediate Similarity NPC134819
0.8012 Intermediate Similarity NPC469456
0.8 Intermediate Similarity NPC205054
0.8 Intermediate Similarity NPC69367
0.8 Intermediate Similarity NPC203020
0.8 Intermediate Similarity NPC239966
0.8 Intermediate Similarity NPC148185
0.7989 Intermediate Similarity NPC473776
0.7989 Intermediate Similarity NPC473205
0.7988 Intermediate Similarity NPC104275
0.7988 Intermediate Similarity NPC1913
0.7988 Intermediate Similarity NPC49173
0.7988 Intermediate Similarity NPC4747
0.7988 Intermediate Similarity NPC43638
0.7987 Intermediate Similarity NPC140722
0.7987 Intermediate Similarity NPC4958
0.7987 Intermediate Similarity NPC473428
0.7987 Intermediate Similarity NPC120728
0.7987 Intermediate Similarity NPC218685
0.7987 Intermediate Similarity NPC92054
0.7978 Intermediate Similarity NPC475299
0.7975 Intermediate Similarity NPC156624
0.7975 Intermediate Similarity NPC172920
0.7975 Intermediate Similarity NPC212808
0.7974 Intermediate Similarity NPC27721
0.7966 Intermediate Similarity NPC71385
0.7966 Intermediate Similarity NPC230670
0.7963 Intermediate Similarity NPC105827
0.7963 Intermediate Similarity NPC310661
0.7963 Intermediate Similarity NPC34965
0.7963 Intermediate Similarity NPC183536
0.7952 Intermediate Similarity NPC293568
0.7952 Intermediate Similarity NPC117943
0.7952 Intermediate Similarity NPC311803
0.7952 Intermediate Similarity NPC477627
0.7952 Intermediate Similarity NPC472859
0.7952 Intermediate Similarity NPC25389
0.795 Intermediate Similarity NPC191154
0.7947 Intermediate Similarity NPC269421
0.7939 Intermediate Similarity NPC287872
0.7939 Intermediate Similarity NPC279732

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC478232 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9068 High Similarity NPD7685 Pre-registration
0.7879 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7834 Intermediate Similarity NPD4628 Phase 3
0.7529 Intermediate Similarity NPD7199 Phase 2
0.7515 Intermediate Similarity NPD4380 Phase 2
0.7514 Intermediate Similarity NPD3818 Discontinued
0.7485 Intermediate Similarity NPD8455 Phase 2
0.7472 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD7054 Approved
0.7471 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD7472 Approved
0.7401 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD6653 Approved
0.7386 Intermediate Similarity NPD6797 Phase 2
0.7381 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD6273 Approved
0.7353 Intermediate Similarity NPD7075 Discontinued
0.7349 Intermediate Similarity NPD7458 Discontinued
0.7345 Intermediate Similarity NPD7251 Discontinued
0.7345 Intermediate Similarity NPD6559 Discontinued
0.7341 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD7074 Phase 3
0.7321 Intermediate Similarity NPD6801 Discontinued
0.7314 Intermediate Similarity NPD7799 Discontinued
0.7312 Intermediate Similarity NPD6002 Phase 3
0.7312 Intermediate Similarity NPD6004 Phase 3
0.7312 Intermediate Similarity NPD7266 Discontinued
0.7312 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD6005 Phase 3
0.7312 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD7808 Phase 3
0.7297 Intermediate Similarity NPD9545 Approved
0.7294 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD1653 Approved
0.7268 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD6799 Approved
0.7239 Intermediate Similarity NPD6190 Approved
0.7235 Intermediate Similarity NPD3817 Phase 2
0.7222 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD37 Approved
0.7215 Intermediate Similarity NPD6355 Discontinued
0.7208 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD5647 Approved
0.7193 Intermediate Similarity NPD4966 Approved
0.7193 Intermediate Similarity NPD4965 Approved
0.7193 Intermediate Similarity NPD4967 Phase 2
0.7188 Intermediate Similarity NPD7033 Discontinued
0.7178 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD7819 Suspended
0.7173 Intermediate Similarity NPD7999 Approved
0.7167 Intermediate Similarity NPD8312 Approved
0.7167 Intermediate Similarity NPD8313 Approved
0.716 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6362 Approved
0.7126 Intermediate Similarity NPD5403 Approved
0.7126 Intermediate Similarity NPD8127 Discontinued
0.7119 Intermediate Similarity NPD7228 Approved
0.711 Intermediate Similarity NPD6234 Discontinued
0.7108 Intermediate Similarity NPD5401 Approved
0.7108 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD230 Phase 1
0.7105 Intermediate Similarity NPD1091 Approved
0.7101 Intermediate Similarity NPD6599 Discontinued
0.7101 Intermediate Similarity NPD7028 Phase 2
0.7089 Intermediate Similarity NPD6233 Phase 2
0.7079 Intermediate Similarity NPD5844 Phase 1
0.7076 Intermediate Similarity NPD5761 Phase 2
0.7076 Intermediate Similarity NPD5760 Phase 2
0.7068 Intermediate Similarity NPD7497 Discontinued
0.7059 Intermediate Similarity NPD7411 Suspended
0.7056 Intermediate Similarity NPD7930 Approved
0.7056 Intermediate Similarity NPD6765 Approved
0.7056 Intermediate Similarity NPD6764 Approved
0.7044 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD2796 Approved
0.7035 Intermediate Similarity NPD5402 Approved
0.7025 Intermediate Similarity NPD3764 Approved
0.7025 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD3751 Discontinued
0.7019 Intermediate Similarity NPD7097 Phase 1
0.7018 Intermediate Similarity NPD1934 Approved
0.7 Intermediate Similarity NPD1933 Approved
0.6994 Remote Similarity NPD5763 Approved
0.6994 Remote Similarity NPD5762 Approved
0.6989 Remote Similarity NPD3787 Discontinued
0.6988 Remote Similarity NPD7236 Approved
0.6987 Remote Similarity NPD2798 Approved
0.6977 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6975 Remote Similarity NPD1510 Phase 2
0.697 Remote Similarity NPD3750 Approved
0.6968 Remote Similarity NPD1876 Approved
0.6961 Remote Similarity NPD7240 Approved
0.6957 Remote Similarity NPD8434 Phase 2
0.6951 Remote Similarity NPD1549 Phase 2
0.6948 Remote Similarity NPD1608 Approved
0.6936 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6936 Remote Similarity NPD5353 Approved
0.6918 Remote Similarity NPD6798 Discontinued
0.691 Remote Similarity NPD6166 Phase 2
0.691 Remote Similarity NPD6168 Clinical (unspecified phase)
0.691 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6909 Remote Similarity NPD1652 Phase 2
0.6906 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6905 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6902 Remote Similarity NPD6784 Approved
0.6902 Remote Similarity NPD6785 Approved
0.6891 Remote Similarity NPD7435 Discontinued
0.689 Remote Similarity NPD1552 Clinical (unspecified phase)
0.689 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6882 Remote Similarity NPD7239 Suspended
0.6879 Remote Similarity NPD2801 Approved
0.6875 Remote Similarity NPD5494 Approved
0.6872 Remote Similarity NPD7583 Approved
0.6871 Remote Similarity NPD3748 Approved
0.6871 Remote Similarity NPD2799 Discontinued
0.6837 Remote Similarity NPD7585 Approved
0.6835 Remote Similarity NPD9494 Approved
0.6832 Remote Similarity NPD4140 Approved
0.6829 Remote Similarity NPD2935 Discontinued
0.6826 Remote Similarity NPD3887 Approved
0.6826 Remote Similarity NPD2354 Approved
0.6823 Remote Similarity NPD6782 Approved
0.6823 Remote Similarity NPD6777 Approved
0.6823 Remote Similarity NPD6781 Approved
0.6823 Remote Similarity NPD6780 Approved
0.6823 Remote Similarity NPD6778 Approved
0.6823 Remote Similarity NPD6779 Approved
0.6823 Remote Similarity NPD6776 Approved
0.6816 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6815 Remote Similarity NPD2797 Approved
0.6813 Remote Similarity NPD3268 Approved
0.6805 Remote Similarity NPD2532 Approved
0.6805 Remote Similarity NPD2534 Approved
0.6805 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6805 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6805 Remote Similarity NPD2533 Approved
0.68 Remote Similarity NPD3882 Suspended
0.6798 Remote Similarity NPD6232 Discontinued
0.6792 Remote Similarity NPD6832 Phase 2
0.6791 Remote Similarity NPD8397 Clinical (unspecified phase)
0.679 Remote Similarity NPD5123 Clinical (unspecified phase)
0.679 Remote Similarity NPD5124 Phase 1
0.6786 Remote Similarity NPD5058 Phase 3
0.6782 Remote Similarity NPD1465 Phase 2
0.6781 Remote Similarity NPD1358 Approved
0.6778 Remote Similarity NPD7473 Discontinued
0.677 Remote Similarity NPD4062 Phase 3
0.6768 Remote Similarity NPD4308 Phase 3
0.6766 Remote Similarity NPD4110 Phase 3
0.6766 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6766 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6763 Remote Similarity NPD6386 Approved
0.6763 Remote Similarity NPD6385 Approved
0.6761 Remote Similarity NPD3749 Approved
0.6753 Remote Similarity NPD17 Approved
0.6747 Remote Similarity NPD5958 Discontinued
0.6747 Remote Similarity NPD2424 Discontinued
0.6746 Remote Similarity NPD1511 Approved
0.6744 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6731 Remote Similarity NPD3972 Approved
0.6731 Remote Similarity NPD9717 Approved
0.6728 Remote Similarity NPD1240 Approved
0.6727 Remote Similarity NPD1551 Phase 2
0.6727 Remote Similarity NPD2438 Suspended
0.6725 Remote Similarity NPD920 Approved
0.6712 Remote Similarity NPD3134 Approved
0.6708 Remote Similarity NPD2313 Discontinued
0.6705 Remote Similarity NPD7768 Phase 2
0.6701 Remote Similarity NPD7584 Approved
0.6687 Remote Similarity NPD447 Suspended
0.6687 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6687 Remote Similarity NPD5735 Approved
0.6683 Remote Similarity NPD7874 Approved
0.6683 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7003 Approved
0.6667 Remote Similarity NPD3705 Approved
0.6667 Remote Similarity NPD1512 Approved
0.665 Remote Similarity NPD7783 Phase 2
0.665 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6647 Remote Similarity NPD3226 Approved
0.6646 Remote Similarity NPD7095 Approved
0.6646 Remote Similarity NPD1607 Approved
0.6646 Remote Similarity NPD3225 Approved
0.6646 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6633 Remote Similarity NPD7698 Approved
0.6633 Remote Similarity NPD8151 Discontinued
0.6633 Remote Similarity NPD7697 Approved
0.6633 Remote Similarity NPD7696 Phase 3
0.6629 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6626 Remote Similarity NPD4307 Phase 2
0.6625 Remote Similarity NPD2861 Phase 2
0.6623 Remote Similarity NPD1241 Discontinued
0.6612 Remote Similarity NPD8470 Clinical (unspecified phase)
0.661 Remote Similarity NPD7058 Phase 2
0.661 Remote Similarity NPD7057 Phase 3
0.6608 Remote Similarity NPD642 Clinical (unspecified phase)
0.6607 Remote Similarity NPD1243 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data